Human amniotic membrane cells may be used for stroke treatment

study by researchers in Australia and other countries has found that injecting human amniotic cells into stroke patients can effectively reduce brain damage and help patients recover.
amniotic membrane is the innermost layer of the placenta and is a translucent film, consisting of a single layer of epithal cells connected to each other. Stroke is a group of diseases with ishemosis and hemorrhagic injury as the main symptoms of the brain, with very high disability rate and mortality rate. Stroke is mainly divided into haemorrhagic stroke (brain haemorrhage) and ishedic stroke (cerebral infarction).
by researchers at the University of Le Drogbo and Monash University in Australia have found that injections of human amniotic epithal cells are expected to be used in ischemic stroke treatment.
researchers found in animal experiments that in stroke 1. After 5 hours of intravenous injection of human amniotic epithal cells, these cells can quickly enter the damaged areas of the brain, significantly reducing inflammation and reducing nerve cell death. Even if the human amniotic epithelial cells are injected 1 to 3 days after stroke, the recovery process can be accelerated and the body's functional recovery can be improved.
, who led the study, said in a press release that injecting human amniotic epithelocytes is an effective cell therapy. Amniotic epithelocytic cells are a type of amniotic stem cells, which retain the characteristics of embryonic stem cells, have strong differentiation potential and immune tolerance, will not be rejected by the human body, will not cause cancer. The amniosis tissue is postpartum waste, which is relatively easy to obtain and does not cause ethical debate.
results have been published in
Journal. It is understood that monash University researchers involved in the study will soon conduct relevant human clinical trials to further assess the feasibility and safety of this method. (Source: Xinhua News Agency)